Should a 59-year-old woman taking NP‑Thyroid (natural desiccated thyroid) 30 mg and levothyroxine 100 µg concurrently continue to take both medications together?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 6, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Should NP Thyroid and Levothyroxine Be Taken Together?

No, this combination of natural desiccated thyroid (NP Thyroid) and levothyroxine should not be continued together—this regimen is not supported by clinical guidelines and creates unnecessary complexity with potential for overtreatment. The patient should be transitioned to levothyroxine monotherapy, which is the standard of care for hypothyroidism 1.

Why This Combination Is Problematic

Lack of Guideline Support

The 2012 AACE/ATA guidelines explicitly state that levothyroxine monotherapy is the treatment of choice for hypothyroidism 1. Desiccated thyroid preparations like NP Thyroid contain both T4 and T3 in a fixed 4:1 ratio by weight, which already provides thyroid hormone replacement 1. Adding levothyroxine on top of this creates:

  • Unpredictable total hormone dosing - You're essentially giving two overlapping thyroid hormone preparations
  • Increased risk of iatrogenic hyperthyroidism - Particularly concerning in a 59-year-old woman at risk for atrial fibrillation and bone loss 1, 2
  • No rational therapeutic basis - If hypothyroidism is inadequately controlled, the solution is adjusting one medication, not layering multiple preparations

Cardiovascular and Bone Risks in This Age Group

At 59 years old, this patient faces specific risks from thyroid hormone overtreatment:

  • Atrial fibrillation risk increases significantly with TSH suppression, especially in patients >60 years 3
  • Accelerated bone loss in postmenopausal women from excessive thyroid hormone 1, 2
  • Cardiovascular mortality may increase with subclinical hyperthyroidism 3

The FDA label explicitly warns about decreased bone mineral density with thyroid hormone over-replacement, particularly in post-menopausal women 2.

Recommended Management Algorithm

Step 1: Assess Current Thyroid Status

Check TSH, free T4, and free T3 levels to determine if the patient is:

  • Euthyroid (TSH 0.45-4.5 mIU/L): Indicates overtreatment—reduce total dose
  • Hypothyroid (TSH >4.5 mIU/L): Inadequate dosing despite dual therapy
  • Suppressed (TSH <0.1 mIU/L): Dangerous overtreatment requiring immediate dose reduction 3

Step 2: Convert to Levothyroxine Monotherapy

Calculate equivalent levothyroxine dose:

  • NP Thyroid 30 mg (½ grain) contains approximately 19 mcg T4 and 4.5 mcg T3
  • Each 1 mcg of T3 is roughly equivalent to 3-4 mcg of T4
  • Total T4 equivalence: 19 + (4.5 × 3.5) ≈ 35 mcg from the NP Thyroid
  • Combined current dose equivalent: ~135 mcg levothyroxine

Start with levothyroxine 125 mcg daily (slightly lower to avoid overtreatment) and recheck TSH in 6-8 weeks 1.

Step 3: Monitor and Adjust

  • Recheck TSH 6-8 weeks after conversion
  • Target TSH: 0.45-4.5 mIU/L for most patients 1
  • Adjust levothyroxine in 12.5-25 mcg increments as needed

Common Pitfalls to Avoid

Pitfall #1: Patient resistance to change Nearly half of patients on desiccated thyroid express preference for it over levothyroxine 4, often due to perceived symptom improvement. However, this preference was not associated with objective quality of life improvements in randomized trials 5, 4. Address patient concerns directly but emphasize safety.

Pitfall #2: Assuming symptoms are thyroid-related If the patient reports persistent symptoms despite biochemical euthyroidism, consider other causes rather than adding more thyroid hormone 6. Psychosocial factors, comorbidities, and unrealistic expectations are more common culprits than inadequate thyroid replacement.

Pitfall #3: Not checking for drug interactions If TSH remains elevated after simplifying therapy, investigate absorption issues. Iron supplements, calcium, proton pump inhibitors, and other medications can significantly impair levothyroxine absorption even with 4-hour dose separation 2, 7. Consider a supervised absorption test if malabsorption is suspected.

Special Considerations for This Patient

Timing of Administration

Levothyroxine should be taken 30-60 minutes before breakfast on an empty stomach with water for optimal absorption 1. This is particularly important when simplifying from combination therapy.

Age-Related Dosing

At 59 years, this patient may require slightly less levothyroxine per kilogram than younger patients due to decreased lean body mass 1. The typical replacement dose is 1.6 mcg/kg, but older patients often need 20-25% less.

Follow-up Intensity

Given the transition from dual therapy, closer monitoring is warranted:

  • TSH at 6-8 weeks post-conversion
  • If stable, repeat at 3 months
  • Then every 6-12 months once stable 1

The bottom line: Combining desiccated thyroid with levothyroxine creates unnecessary complexity and risk without evidence of benefit. Transition to levothyroxine monotherapy with appropriate dose calculation and monitoring.

Related Questions

Is there a required washout period when switching from levothyroxine (Synthroid) to Armour Thyroid (desiccated thyroid extract)?
What are the differences between desiccated thyroid (natural desiccated thyroid) and levothyroxine in the treatment of primary hypothyroidism?
What is the levothyroxine dose equivalent to 105 mg of Armour Thyroid (desiccated thyroid)?
How should the dose of Armour Thyroid (desiccated thyroid) be adjusted when thyroid‑stimulating hormone (TSH) is elevated?
What is the appropriate levothyroxine dose conversion for a patient taking NP Thyroid (desiccated thyroid extract) 15 mg once daily?
How should I diagnose and manage a chronic chyle leak from an iatrogenic thoracic duct injury sustained during a C5‑C6 anterior cervical discectomy and fusion (ACDF), which has resulted in a mediastinal cyst, protein‑loss malnutrition, and systemic symptoms such as facial swelling, vision changes, tinnitus, pruritus, and brittle hair and nails?
For a patient who underwent left pelvic vein embolization with coil placement, should assessment of possible coil migration be referred to a vascular surgeon?
What is the prognosis for Merkel cell carcinoma and what are the recommended treatment options?
What is the appropriate fluid choice and management for a patient with hypochloremia (serum chloride 91.2 mmol/L) given normal sodium and potassium levels?
What further testing is indicated for a 46-year-old woman with self‑resolving palpitations over the past three days?
In a patient with a solitary kidney, is dose adjustment of ciprofloxacin required?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.